A microfluidic-enabled smartplate for precision culture, control and monitoring of living cells. NAICS 5417715 PSC AN12 contractor duns 078744267
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95018C00012
- Awardee
-
Cairn Biosciences Inc. UEI LWZWY2J1M2J4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,499,968
Award facts
- Contract value 100% obligated
- $1,499,968.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,499,968 |
About this award
This federal contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Cairn Biosciences Inc., a woman-owned small business, for the development of a microfluidic-enabled smartplate for precision culture, control, and monitoring of living cells. The contract, awarded under the Small Business Innovation Research (SBIR) Program Phase II, has a firm fixed price of $1,499,968.00 and a completion date of May 31, 2020. The contract was set aside for small businesses. The product being delivered under this contract aligns with the agency's mission to advance translational sciences.
Quick answers
Who was awarded contract 75N95018C00012?
75N95018C00012 was awarded to Cairn Biosciences Inc. by National Institute on Drug Abuse (National Institutes of Health) on April 12, 2018.
How much is contract 75N95018C00012 worth?
The government has obligated $1,499,968 on 75N95018C00012.
Which agency awarded contract 75N95018C00012?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95018C00012, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95018C00012 competed?
The extent of competition for 75N95018C00012 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award